DBS Group Holdings Ltd – Stellar ROE supported by recurrent interest income February 19, 2019 762

PSR Recommendation: BUY Status: Maintained
Last Close Price: S$43.71 Target Price: S$29
  • FY18 Revenue and PATMI met our estimates.
  • FY18 NIM expanded 13 bps YoY to 1.85% (FY17: 1.75%). 4Q18 NIM rose 1 bps QoQ to 1.87% (3Q18: 1.86%).
  • Loans grew 6.7% YoY, driven by non-trade corporate loans across the region.
  • Allowances declined 71.0% YoY due to accelerated provisions made for weak oil and gas support service last year. NPL ratio improved to 1.6% (4Q17: 1.7%).
  • Full-year ROE rose 2.4% to 12.1%, the highest since FY2007.
  • A proposed final dividend of $0.60/share, bringing full-year dividend to $1.20/share.
  • Maintain BUY at an unchanged target price of S$29.00.

 

The Positives

+ NIM at an almost three-year high. 4Q18’s NIM touched 1.87%, meeting the full year guidance and expanding 9bps YoY and 1 bps QoQ. NIM expansion was boosted by higher interest rates in Singapore and Hong Kong. Loan, interbank and securities yields improved 59bps YoY, 19bps YoY and 34bps YoY; while the cost of funds rose 46bps YoY. Higher interest rates in Singapore and Hong Kong were offset by lower NIM from Treasury Market (TM) activities. Excluding TM, FY18 NIM would be 2.06%. We expect the cost of funds to rise as more deposits migrate from CASA to fixed deposits and bonds in a rising interest rate environment. With the recent dovish tone on future rate hikes by the U.S. Federal Reserve, we lower our NIM estimates for FY19e from 1.94% to 1.91%.

 

+ Loan growth stable at mid-single digit of 6% YoY, led by regional broad-based non-trade corporate loans (+12% YoY) and consumer loans (+3% YoY). Consumer loan growth was softer in 2H18 due to property cooling measures. Trade loans declined 6% as maturing loans were not renewed due to rising interest rates. DBS’s market share of Singapore housing loan remains healthy at 31%. We believe that the slowdown in mortgage loans will persist and loan growth to be dampened by rising interest rates and geopolitical events. Hence we tone down our FY19e loan growth estimates from 6.7% to 6.0%.

 

+ Allowances halved and specific provision at 19bps of total loans. The plunge in allowances was due to substantially accelerated provisions made for the O&G sector last year. 

 

+ Hong Kong’s full-year earnings surged 40% YoY. Hong Kong’s NII grew 30% YoY, driven by rising interest rates which gave a 27 bps increase in NIM to 2.01%. The rise in HIBOR in Hong Kong has become much more significant with a growing CASA base and loans growth was robust at 11% YoY. Hong Kong contributed 20% to total revenue.  

 

The Negatives

– 4Q18’s Treasury Markets income declined 54% YoY to $92mn, the lowest ever recorded. Unfavourable market conditions resulted in lower contributions from equity and credit activities. Compared to the previous quarter, total income declined 59% due to lower contributions across all products. However, we believe the greater proportion of high-returns businesses such as the Wealth Management and Cash and SFS in DBS’s franchise mix will be able to offset the near term contraction in Treasury Markets income. The Wealth Management and Cash management businesses are already contributing to a third of the bank’s revenue.

 

– Full-year CIR rose to 44.1% from FY17’s 43.7% due to higher reported expenses from Treasury Markets and ANZ of around +8% YoY. Excluding the impact from ANZ and Treasury Markets, FY18’s underlying CIR would be stable at 41%, similar to FY17. Operating expenses increased 8.2% YoY in 4Q18, faster than operating income’s growth of 6.2% YoY; due to more costs than income brought on by ANZ which accounted for 6% of the increase in expenses. More costs could be expected in 2019 as DBS expands into India.

 

Outlook

More NIM expansion to be expected. While it generally takes a few months for loans pegged to floating rates to reprice, it takes a couple of years for a fixed rate loan to do so. Hence, even if the Fed pauses in their rate hikes, a large portion of the rise in interest rates has yet to be repriced into Singapore’s books. More repricing of loans expected in 2019 and beyond.

Mortgage book growth to decelerate due to property cooling measures. Guidance for new mortgage loan formation has been revised to $1.5-2.0bn in 2019, a decrease from $2.5bn guided for FY18e. However, loan growth could be supported by demand from Chinese businesses moving out of China and fiscal stimulus as countries including Thailand, Indonesia and India prepare for elections this year.

Macroeconomic slowdown and volatile markets. Management expressed concerns about the impact of uncertain geopolitical events such as the trade war, Brexit and US election, resulting in synchronised economic slowdown globally. In our opinion, the ability and resilience DBS’s franchise will allow it to capitalize on the region’s prospects as companies shift their supply chain out of China and into South-East Asia.

 

Investment Actions

We maintain BUY at an unchanged target price of S$29.00.

Despite the softer expectation of loans growth due to market headwinds, NIM will still be on a positive trajectory as trade issues will impact trade volumes more significantly than overall margins. The banking sector will enjoy greater pricing power as the US continues to raise its interest rates. Looking forward, asset quality is expected to be stable, and greater cost efficiencies will provide upside to earnings. DBS remains attractive with a dividend yield of 4.8%.

 

Key risks include (i) lower pass-through of interest rates; (ii) lesser U.S. Federal Reserve rate hikes; (iii) market volatility continues to pressure Treasury Market revenues downwards; (iv) weaker sentiments due to trade tensions.

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

About the author

Profile photo of Tin Min Ying

Tin Min Ying
Research Analyst
Phillip Securities Research Pte Ltd

Min Ying covers the Banking and Finance sectors. She has experience in external audit and corporate tax roles.

She graduated with a Bachelor of Accountancy with a major in Finance from SMU.

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!